Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00041964 · ClinicalTrials.gov registry record

A Study of HIV Levels During Pregnancy and After Childbirth

A clinical trial of HIV Infections and Pregnancy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
129
Enrollment target
20
Study locations

NCT00041964: Completed study of HIV Infections and Pregnancy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00041964 is a study of HIV Infections and Pregnancy that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 129 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00041964, a study of HIV Infections and Pregnancy, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
129 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to find out if HIV-infected pregnant women taking anti-HIV drugs have an increased amount of HIV in their blood (viral load) after having the baby. The purpose of A5153s, a substudy of A5150, is to characterize two anti-HIV drugs (nelfinavir \[NFV\] and lopinavir/ritonavir \[LPV/r\]) in HIV-infected women during pregnancy and after childbirth. Sometimes pregnant women have an increase in their HIV viral load after their baby is born. This study will try to find out how often this happens. It will also examine possible reasons why the increase in viral load occurs.

Conditions Studied

HIV Infections Pregnancy

Study Locations (20)

California

  • Los Angeles County Medical Center/USC - Los Angeles
  • UCLA School of Medicine - Los Angeles
  • UCSD Mother, Child & Adolescent HIV Program - San Diego
  • San Francisco General Hosp - San Francisco

Illinois

  • Northwestern University - Chicago
  • Cook County Hosp Core Ctr - Chicago
  • Rush Presbyterian - Saint Luke's Med Ctr - Chicago
  • Chicago Childrens Memorial Hospital (Pediatric) - Chicago

New York

  • NYU/Bellevue - New York
  • Columbia University - New York
  • State Univ of New York at Stony Brook - Stony Brook

Michigan

  • Hutzel Hospital - Detroit
  • Childrens Hospital of Michigan - Detroit

Alabama

  • Univ of Alabama at Birmingham - Birmingham

Florida

  • Univ of Florida- Health Science Ctr - Jacksonville

Georgia

  • Emory Univ - Atlanta

Hawaii

  • University of Hawaii - Honolulu

Trial Details

FieldValue
Enrollment Target 129 participants
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00041964 record still lists

NCT00041964 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00041964 names 20 study sites across 11 states, led by California, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT00041964 about?

NCT00041964 is a clinical study titled "A Study of HIV Levels During Pregnancy and After Childbirth". The purpose of this study is to find out if HIV-infected pregnant women taking anti-HIV drugs have an increased amount of HIV in their blood (viral load) after having the baby. The purpose of A5153s, a substudy of A5150, is to characterize two anti-HIV drugs (nelfinavir \[NFV\] and lopinavir/ritona...

What is the current status of trial NCT00041964?

This trial is currently completed. The enrollment target is 129 participants.

What conditions does trial NCT00041964 study?

This clinical trial studies the following conditions: HIV Infections, Pregnancy.

Who is sponsoring clinical trial NCT00041964?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00041964 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00041964's enrollment target sits among peer trials

129 231st of 542 higher than 310 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03619850 · 129 participants · Phase 3

    A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  • NCT05704361 · 129 participants · Phase 1

    A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

  • NCT05919849 · 129 participants · Phase 1

    Supporting Parents in Affirming Their Children's Experiences of Stigma

  • NCT06313749 · 129 participants · NA

    Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

Related registry views

Source: ClinicalTrials.gov NCT00041964, the US trial registry maintained by the National Library of Medicine. NCT00041964 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.